Skip to content

Gut microbes linked to immune activation, HIV disease progress, may explain long-term CD4 loss

After 48 weeks of study, and 24 weeks in the real world, darunavir continues to show staying power

TB-related immune reaction to HIV therapy occurs 20 months after TB treatment first started - is this a record?

A simpler, cheaper way to assess HIV-positive children’s health

Emergence of resistance mutations: a comparison between drug classes

TB transmission in healthcare settings and improving infection control

10% of new TB cases involve drug resistance

Most HIV-positive patients do as well as HIV-negative counterparts following surgery

CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences